Immuneering said LetsWinPC highlighted new AACR data showing atebimetinib may reduce pancreatic tumor volume while preserving body mass. The company also launch

BWB News TV • 2026-11-13 17:36 UTC • By Billy Odell Tucker-Robinson

Immuneering said LetsWinPC highlighted new AACR data showing atebimetinib may reduce pancreatic tumor volume while preserving body mass. The company also launched three new trials in pancreatic and anaplastic thyroid cancers.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly